PiLeJe Industrie, Naturopôle Nutrition Santé, Les Tiolans, F-03800 Saint-Bonnet-de-Rochefort, France.
Food Funct. 2020 Jan 29;11(1):722-729. doi: 10.1039/c9fo01144g.
The objective of this study was to evaluate the benefits of a new extraction process, the ipowder® technology, applied to Melissa officinalis L. Compared to M. officinalis ground dry leaves, the ipowder® had a similar phytochemical fingerprint but contained twice the concentration of rosmarinic acid (by HPTLC and HPLC) and had a two-fold greater antioxidant activity (DPPH* method). In vitro digestion experiments (TIM-1 model) showed better availability of rosmarinic acid for intestinal absorption with the ipowder® than with ground dry leaves, manifested by a three-fold reduction in the quantity of ingested product needed for delivery of the same amount of rosmarinic acid into the upper gastro-intestinal tract. This study shows that the ipowder® technology preserves all the original plant compounds intact while making some active ingredients more accessible and available to exert their effects. To obtain a given effect, the amount of ipowder® extract to ingest will therefore be lower; a reduction in the daily dosage will be more convenient for the patient and will improve patient compliance with supplementation.
本研究旨在评估 ipowder® 技术这一新的提取工艺给 Melissa officinalis L. 带来的益处。与 Melissa officinalis 干燥粉碎叶相比,ipowder® 具有相似的植物化学指纹图谱,但迷迭香酸的浓度高出两倍(通过 HPTLC 和 HPLC 检测),且具有两倍的抗氧化活性(DPPH*法)。体外消化实验(TIM-1 模型)表明,与干燥粉碎叶相比,ipowder® 中迷迭香酸的肠道吸收利用率更高,表现在进入上胃肠道的相同量迷迭香酸所需摄入的产品量减少了三倍。这项研究表明,ipowder® 技术在保持植物原有化合物完整的同时,使某些活性成分更易获取和利用,从而发挥其作用。因此,为了达到相同的效果,摄入的 ipowder® 提取物的量将会减少;减少每日剂量将更方便患者,提高患者对补充剂的依从性。